10/22/2026
VA faces challenges in psychedelic treatment rollout
Federal officials discuss the complexities of psychedelic access for veterans.
Topic archive
6 stories
10/22/2026
Federal officials discuss the complexities of psychedelic access for veterans.
10/21/2026
Preclinical study explores ibogaine and citalopram combination for depression.
10/8/2026
Study finds significant symptom improvement in PTSD, depression after ibogaine treatment.
9/10/2026
The FDA highlights its evolving approach to psychedelic therapies amid a mental health crisis.
8/21/2026
Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.
7/24/2026
The Tijuana-based center marks a milestone in ibogaine treatment for substance use disorder.